{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:47:32Z","timestamp":1791413252280,"version":"4.3.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pheochromocytomas (PHEOs) are neural crest-derived tumors originating from the chromaffin cells of the adrenal medulla and were recognized as one of the subtypes of paragangliomas by the World Health Organization in 2022. <jats:sup>68<\/jats:sup>Ga-labeled somatostatin analog (<jats:sup>68<\/jats:sup>Ga-DOTA-NOC, <jats:sup>68<\/jats:sup>Ga-DOTA-TOC, and <jats:sup>68<\/jats:sup>Ga-DOTA-TATE) PET imaging has shown significant performance compared with <jats:sup>123<\/jats:sup>MIBG scintigraphy in the diagnosis of paragangliomas. It is now known that fibroblast activation protein (FAP) is overexpressed by various cancer-associated fibroblasts, including PHEOs. We would like to present the findings of <jats:sup>68<\/jats:sup>Ga-DOTA-FAPI-46 PET\/CT and <jats:sup>68<\/jats:sup>Ga-DOTA-TATE PET\/CT imaging performed for restaging on a 42-year-old man diagnosed with metastatic PHEO.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005481","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T14:00:20Z","timestamp":1728050420000},"page":"e622-e624","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["68Ga-DOTA-FAPI-46 PET\/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Rahime","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Can","family":"Balo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Erg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik Fikret","family":"\u00c7ermik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-8883","authenticated-orcid":false,"given":"Esra","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study","volume":"106","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","article-title":"Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2967\/jnumed.107.047738","article-title":"111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","article-title":"Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, an 111In-pentetreotide scintigraphy","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00259-002-0939-6","article-title":"Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas","volume":"29","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","first-page":"685","article-title":"[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jcem.86.2.7194","article-title":"Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","article-title":"Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data","volume":"28","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00259-011-1962-2","article-title":"Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00259-012-2119-7","article-title":"A comparison of the performance of 68Ga-DOTATATE PET\/CT and 123I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00259-014-2892-6","article-title":"(68)Ga-DOTATOC PET\/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT\/CT","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nucmedbio.2019.04.003","article-title":"68Ga-DOTATOC PET\/CT in the localization of head and neck paraganglioma compared with 18F-DOPA PET\/CT and 123I-MIBG SPECT\/CT","volume":"71","year":"2019","journal-title":"Nucl Med Biol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","article-title":"68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00330-011-2289-x","article-title":"Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study","volume":"22","year":"2012","journal-title":"Eur Radiol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s00259-013-2548-y","article-title":"A retrospective comparison between 68Ga-DOTA-TOC PET\/CT and 18F-DOPA PET\/CT in patients with extraadrenal paraganglioma","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2967\/jnumed.112.115485","article-title":"68Ga-DOTANOC PET\/CT for baseline evaluation of patients with head and neck paraganglioma","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00259-013-2598-1","article-title":"Diagnostic accuracy of (68)Ga-DOTANOC PET\/CT imaging in pheochromocytoma","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13139-015-0331-7","article-title":"Diagnostic performance of (68)Ga-DOTATATE PET\/CT, (18)F-FDG PET\/CT and (131)I-MIBG scintigraphy in mapping metastatic pheochromocytoma and paraganglioma","volume":"49","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/ijem.ijem_307_21","article-title":"The utility of 68Ga-DOTATATE PET\/CT in localizing primary\/metastatic pheochromocytoma and paraganglioma: Asian Indian experience","volume":"25","year":"2021","journal-title":"Indian J Endocrinol Metab"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.3390\/cancers14163886","article-title":"Performances of functional and anatomic imaging modalities in succinate dehydrogenase A\u2013related metastatic pheochromocytoma and paraganglioma","volume":"14","year":"2022","journal-title":"Cancer"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0042-1751030","article-title":"Comparison of the sensitivity of 68Ga-DOTATATE PET\/CT with other imaging modalities in detecting head and neck paraganglioma: experience from Western India","volume":"21","year":"2022","journal-title":"World J Nucl Med"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2967\/jnumed.116.187690","article-title":"Functional imaging signature of patients presenting with polycythemia\/paraganglioma syndromes","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00259-023-06497-6","article-title":"The inferior performance of [68Ga]Ga-FAPI-04 PET\/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors","volume":"51","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:07:23Z","timestamp":1750532843000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005481"}},"subtitle":["Comparison With 68Ga-DOTA-TATE PET\/CT"],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005481","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}